Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder
- 1 February 2000
- Vol. 55 (2) , 223-226
- https://doi.org/10.1016/s0090-4295(99)00383-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 1999
- CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?Journal of Urology, 1998
- Urinary NMP22TM and Karyometry in the Diagnosis and Follow-Up of Patients with Superficial Bladder CancerEuropean Urology, 1998
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial CancerEuropean Urology, 1997
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Soluble forms of the adhesion molecule E-cadherin in urine.Journal of Clinical Pathology, 1995
- Clinical Evaluation of Urinary and Serum Carcinoembryonic Antigen in Bladder CancerJournal of Urology, 1975